VADUZ, Liechtenstein, May 27, 2025 /PRNewswire/ -- Implantica AG (publ.) reports successful pre-launch activities in the U.S., pending FDA approval, with European real-world clinical evidence generating much interest from U.S. surgeons. Several presentations on RefuxStop™ were held at...
Read More Details
Finally We wish PressBee provided you with enough information of ( Implantica's RefluxStop™ stimulates intensive dialogue at DDW, the world's largest Digestive Disease conference, held in the U.S. )
Also on site :
- Tears and Shock: First Islander Sent Home on ‘Love Island USA’ Season 7
- A Gaza-bound aid boat carrying Greta Thunberg and other activists has been diverted to Israel
- 'Hamilton’ Original Cast Reunites at 2025 Tony Awards & Fans Are Saying the Same Thing